# Phase 2 verification — 19 October 2026

Phase 2 implements the database foundation only. Phase 1 UI source files, mock fixtures, types and logo remain unchanged. No hosted project is linked, no accounts/credentials are created, no real patient data is used and no application deployment or Git push is performed.

## Checks executed

| Check                         | Verified result                                                                                                                        |
| ----------------------------- | -------------------------------------------------------------------------------------------------------------------------------------- |
| Clean SQL migration execution | Pass: repeated clean PostgreSQL 17.10 clusters, all seven application tables                                                           |
| `npm run db:migrations:check` | Pass: Supabase CLI actually applied `20261019141747_database_foundation.sql`; migration history and file version both `20261019141747` |
| `npm run test:db`             | Pass: 22 database tests, zero failures/skips                                                                                           |
| Database type generation      | Pass: generated `src/types/database.ts` from applied PostgreSQL schema; reproducibility checked by the database suite                  |
| `npm run db:advisors`         | Pass: Supabase CLI security advisor returned an empty findings list at warning/error levels on the isolated local database             |
| `npm run typecheck`           | Pass: generated Next.js route types and strict TypeScript check                                                                        |
| `npm run lint`                | Pass: ESLint, zero warnings                                                                                                            |
| `npm run build`               | Pass: optimized Next.js production build, all five required UI routes                                                                  |
| `npm run test:e2e`            | Pass: all 13 existing Phase 1 Chromium tests, 31.3 seconds                                                                             |
| Phase 1 source preservation   | Pass: all 21 pre-existing `src/` files match their pre-change SHA-256 hashes                                                           |
| Branding preservation         | Pass: root/public logo copies retain their original identical SHA-256 hashes                                                           |

The CLI's generic "remote database" message for an explicit `--db-url` does not imply hosted access: both advisor and migration checks point only to a newly generated `127.0.0.1` test cluster. The harness never consumes user-supplied remote database URLs. Each test cluster is stopped and its own checked directory removed after verification.

## Database coverage

The 22 tests cover the schema, UUID primary keys, required FKs/checks/unique constraints, RLS flags, exact generated types, anonymous denial, pharmacy denial of clinical data, own-identity reads, unassigned/inactive identities, resistance to role spoofing through editable metadata, denied identity provisioning/membership switches, active-doctor draft operations, denied privilege/issuance/digest/timestamp writes, issued/terminal header/item immutability, protection of patient verification fields linked to issued history, invalid pharmacist/doctor relationships, second-doctor rejection, invalid quantities/digests/expiry/incomplete issuance fields, denied application dispensing writes, complete-only dispensing invariants, append-only audit/dispensation history, safe audit metadata and provenance, and private-function privileges/search paths.

RLS assertions actually run as non-BYPASSRLS `authenticated` or `anon` roles, with transaction-local test UIDs. They do not use owner queries as evidence of client denial. Fixtures, SQL-level constraints and introspection use trusted owner access separately. The audit-provenance assertion temporarily resets to the owner only to inspect the protected audit row, after creating its synthetic patient through the actual authenticated doctor role.

The duplicate-dispensing concurrency test uses **two distinct live PostgreSQL connections and transactions**. One holds its uncommitted insertion; the test observes the second blocked on a lock, commits the first, then verifies SQLSTATE `23505` for the second and exactly one completion row. There is no real dispensing endpoint or real recorded transaction. A separate test exercises item-edit/lifecycle serialization and rejects subsequent item changes.

## UI regression coverage

The unchanged browser suite verifies Arabic RTL/local fonts/logo loading, login validation without authentication or credential transmission, internal navigation, table filters/empty states/details, prescription form validation and review/edit state, no persistence or write requests, read-only pharmacy results, draft/already-dispensed cases, explicit local simulation confirmation and reset, not-found handling, root redirection and print emulation. All five screens and pharmacy confirmation fit 320, 768 and 1440 px; a complete 320 px entry/review flow passes.

## Files added/changed

- Added `supabase/config.toml` and `supabase/migrations/20261019141747_database_foundation.sql`.
- Added `.env.example`, `src/lib/supabase/{config,client,server}.ts` and generated `src/types/database.ts`.
- Added `tests/database/{bootstrap.sql,local-postgres.mjs,foundation.test.mjs}` and `scripts/{database-types,database-advisors,database-migrations}.mjs`.
- Updated `package.json`/lockfile with pinned Supabase packages and development tooling/scripts.
- Updated `.gitignore` and ESLint ignores for secrets/local test data. `.env.example` is explicitly exempted from the `.env*` ignore rule; no `.env.local` was created.
- Updated Playwright's file match so node database tests run only under the database runner.
- Updated `README.md`; added `docs/database.md` and this verification report. Historical Phase 1 verification is retained.

## Pending configuration and verification

- **Hosted connection/application is pending.** No dedicated target project reference or application credentials were configured. Unrelated connected projects were left untouched. Identify the correct dedicated project, inspect its existing schema/history, then review/apply the migration using the steps in `database.md`. Never reset an existing remote database.
- **The full Supabase local service stack was not run.** Docker is unavailable. Native PostgreSQL verifies real SQL, locking, constraints and RLS; its minimal Auth test context does not verify GoTrue, signed JWTs, PostgREST, SSR refresh behavior or hosted platform settings.
- **Auth and business workflows remain out of scope.** Client factories are prepared but never called by the UI. Phase 3 must add and verify authentication/session handling and trusted identity provisioning only after approval; issuance/code generation/lookup/dispensing services remain for their respective later phases.
- **Dependency audit:** the runtime-only npm audit reported zero vulnerabilities. The full npm audit reported five high-severity development-tool findings in the existing Next.js ESLint/micromatch/braces chain. No force upgrade or unrelated dependency change was made; these findings are not a claim of a runtime vulnerability fix.
- **Git state:** the workspace has no Git repository metadata. Migration/configuration source files and ignore rules are prepared, but no commit or push was created. Track them in the intended repository when version control is configured.
- No legally recognized digital signature, clinical readiness, production security certification, real device/other-browser or physical-print verification is claimed.

No known local Phase 2 schema/test failures remain. Hosted configuration and hosted Auth/API verification remain explicit gates before authenticated clinical workflows. Stop here for review; Phase 3 has not begun.
